VIPPSTAR-G1 Digital Early Intervention for Visual Impairment

计划入组 150 人 · 首次发布于 2026 年 7 月 21 日

A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults

计划入组 170 人 · 首次发布于 2023 年 6 月 13 日

A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1

计划入组 20 人 · 首次发布于 2005 年 10 月 14 日

LOC-G1

ADE-G1

INFLUENZA G1 mHA

G1 Therapeutics

United States

ALIFE HEALTH S A S

Colombia

SEGURIDAD MEDICA SEGANEST S A S

Colombia

Pharmacosmos Group Acquires G1 Therapeutics for $405 Million to Expand COSELA Access for Cancer Patients

Dana-Farber Researchers Launch Phase 1 Trial of Novel Cyclin Inhibitor for Small Cell Lung Cancer

4D Path's AI Platform Predicts Chemotherapy Response in Triple-Negative Breast Cancer Using Standard Biopsy Images